Chargement en cours...
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
Background: Carfilzomib’s (Cfz) adverse events in myeloma patients include cardiovascular toxicity. Since carfilzomib’s vascular effects are elusive, we investigated the vascular outcomes of carfilzomib and metformin (Met) coadministration. Methods: Mice received: (i) saline; (ii) Cfz; (iii) Met; (i...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2020-07-01
|
| Collection: | International Journal of Molecular Sciences |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/1422-0067/21/15/5185 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|